What is the main purpose of this 10-Q filing?

This 10-Q filing from McKesson Corporation serves to provide investors and the public with a quarterly update on the company's financial performance and condition, as required by the U.S. Securities and Exchange Commission (SEC) for publicly traded companies. It covers the operational and financial activities during the three months ended December 30, 1994.

Where can I find the detailed financial statements for this period?

The provided text is a directory listing of the filing's components. To access the detailed financial statements, including income statements, balance sheets, and cash flow statements, you would need to locate the full 10-Q filing document itself, likely through the SEC's EDGAR database or a financial data service that archives these historical filings.

What are the key financial metrics I should look for in this filing?

When reviewing the full 10-Q, key financial metrics for investors would typically include revenue growth, gross profit margins, operating income, net income, earnings per share (EPS), cash flow from operations, and the company's overall debt and equity position. Changes in these metrics compared to previous periods are crucial for assessing performance trends.

Is this filing relevant for current investment decisions?

This filing is from February 1995, making it a historical document. While it provides insight into McKesson's financial reporting at that specific time, it is not directly relevant for making current investment decisions. Investors should always consult the most recent SEC filings and conduct thorough due diligence on the company's current financial health and future prospects.

MCK 10-Q Quarterly Report Q3 FY1995 — Revenue, Net Income, EPS

Summary

McKesson Corporation's 10-Q filing for the period ending December 30, 1994, provides a snapshot of its financial performance during the third quarter of its fiscal year. While the filing details are sparse in the provided text, it indicates a company actively engaged in its operations and subject to SEC reporting requirements. Investors should note that this is a historical filing from 1995, and current financial performance and strategic direction may differ significantly. As a distributor of pharmaceuticals and healthcare products, McKesson's business is inherently tied to healthcare trends, regulatory changes, and supply chain efficiency. This filing represents a point in time for the company, and a comprehensive understanding would require reviewing subsequent filings and historical data to assess growth, profitability, and market position over time.

Key Highlights

1McKesson Corporation filed its quarterly report (10-Q) on February 13, 1995, for the period ending December 30, 1994.
2The filing pertains to the third quarter of McKesson's fiscal year.
3This is a historical document from 1995, providing a look at the company's status at that time.
4The provided text is a directory listing of the filing's contents, not the financial statements themselves.
5Investors seeking detailed financial information (revenue, profit, balance sheet, cash flow) will need to access the full 10-Q document, likely available through SEC's EDGAR database or financial data providers.
6The filing signifies McKesson's compliance with SEC reporting regulations during that period.

MCKESSON CORP Quarterly Report for Q3 Ended Dec 31, 1994

Summary

Key Highlights

Frequently Asked Questions